Antibiotic resistance fight: can a website change how doctors prescribe?

NCT ID NCT04028830

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are testing whether a bundle of actions can reduce antibiotic prescribing by general practitioners. The bundle includes visits from medical representatives who discuss antibiotic resistance, challenge common misconceptions, give feedback on prescribing habits, and demonstrate an online decision-support tool called Antibioclic. The trial compares this full bundle to visits without the website demo and to usual care. About 2,500 general practitioners in France are assigned to one of these groups, and researchers track the total volume of antibiotics they prescribe over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a bundle intervention including visits by medical representatives and a decision-support website called Antibioclic
What this could lead to
If the intervention works, it could offer a practical way to reduce unnecessary antibiotic use and slow the rise of resistant infections.
What could go wrong
The trial may show that the website and visits do not change prescribing habits. Changing long-standing routines is hard, and the results might not apply outside the French health system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,501 people

The number who actually took part.

Started

Jul 2019

Finished

Jan 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * GPs practicing on one of the 5 departments of the study having seen at least 100 different patients (whatever the age) during the year preceding the evaluation. Exclusion Criteria: * Will not be included attending GPs 1. who will be identified as having a particular exercise. And / or 2. that will already be integrated into an antibiotic prevention program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antibiotic resistance are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital

    Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.